---
id: vocabulary
title: VOCABULARY
hide_title: true
---

##### Top

# Vocabulary

Value sets supporting cohort definitions. Listing of value sets is in alphabetical order. Some value sets refer to an outside source or repository, and others are expanded here.

### BCG Vaccine Products for Intravesical Use​ VS
​
Scope/Purpose: Identifies BCG vaccine products for intravesical use

Inclusions: Live BCG for intravesical use

Exclusions: None

| Code | Description | Code System | Version | Status |
|-----|------|------|------|-----|
| 90586 | Bacillus Calmette-Guerin vaccine (BCG) for bladder cancer, live, for intravesical use​​ | HCPCS​ | 2019AB | Active
| ​19 | Bacillus Calmette-Guerin vaccine | CVX | ​ | Active


### Confirmed COVID-19 Infection VS

Location: VSAC

OID: [2.16.840.1.113762.1.4.1032.117](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/20200410)

Code Systems: ICD10CM, SNOMEDCT

Type: Grouping

### Convalescent Serum of COVID-19 Products VS

TBD

### Intravesical Administration of BCG Procedure VS

Scope/Purpose: Identifies procedures for intravesical administration of live BCG vaccine. Used to identify patients who received BCG as cellular therapy for bladder cancer.

Inclusions: Procedures specific to the administration of live BCG into the bladder​ (active and inactive terms)

Exclusions: Procedures not specific to BCG​ AND Administration of BCG other than in the intravesical space

| Code | Description | Code System | Version | Status |
|-----|------|------|------|-----|
| J9031 | Bcg (intravesical) per instillation​ | HCPCS​ | 2020 | Inactive |
| J9030​ | Bcg live intravesical instillation, 1 mg​ | HCPCS | 2020​ | Active |
​301879009​ | Instillation of bacillus Calmette-Guerin into the bladder (procedure)​ | SNOMED CT | 202003​ | Active |

### Intravesical Administration of Therapeutic Agent Procedure VS

Scope/Purpose: Identifies procedures indicative of intravesical administration of therapeutic agent.

Inclusions: Procedures representing the administration of unspecified therapeutic agent into bladder

Exclusions: Procedures specific to BCG (covered by [Intravesical Administration of BCG Procedure VS](#intravesical-administration-of-bcg-procedure-vs))

| Code | Description | Code System | Version | Status |
|-----|------|------|------|-----|
| 51720 | Bladder instillation of anticarcinogenic agent (including retention time)​ | CPT​ | 2019AB | Active
| ​44194005 | Urinary bladder instillation of anticarcinogenic agent (procedure)​ | SNOMED CT | 202003​ | Active
| ​712753009 | Administration of chemotherapeutic agent into bladder via intravesical route (procedure) | SNOMED CT | 202003​ | Active

### Intravesical Route VS

Scope/Purpose: Represent the administration route directly into urinary bladder

| Code | Description | Code System | Version | Status |
|-----|------|------|------|-----|
| ​372471009 | Intravesical route (qualifier)​ | SNOMED CT | 202003​ | Active
| 261102005 | Intravesical approach (qualifer) | SNOMED CT | 202003​ | Active

### Invasive Mechanical Ventilation VS

TBD

### Respiratory Condition VS

Scope/Purpose: Identifies patients with signs and symptoms of respiratory problems

Location: Not published

Code Systems: ICD-10-CM

Code Range: J00-J99


### SARS Coronavirus 2 Qualitative Laboratory Test VS

Location: VSAC

OID: [2.16.840.1.113762.1.4.1032.109](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/20200417)

Code System: LOINC

Type: Extensional

### SARS Related Qualitative Laboratory Test VS

Location: VSAC

OID: [2.16.840.1.113762.1.4.1032.113](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.113/expansion/20200410)

Location: VSAC

Code System: LOINC

Type: Extensional





#### hold for later use

| Name                                                             | Code System       | Type        | VSAC OID                 | # Values |
| ---------------------------------------------------------------- | ----------------- | ----------- | ------------------------------ | -- |
| Confirmed COVID19 Infection                               | ICD10CM, SNOMEDCT | Grouping    | [2.16.840.1.113762.1.4.1032.117](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/20200410) | 2  |
| Confirmed COVID19 Infection ICD10CM                       | ICD10CM           | Extensional | [2.16.840.1.113762.1.4.1032.110](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.110/expansion/20200410) | 1  |
| Confirmed COVID19 Infection ICD10CM Provisional           | ICD10CM           | Extensional | [2.16.840.1.113762.1.4.1032.105](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.105/expansion/20200410) | 0  |
| Confirmed COVID19 Infection SNOMEDCT                      | SNOMEDCT          | Extensional | [2.16.840.1.113762.1.4.1032.114](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.114/expansion/20200410) | 1  |
| Hydroxychloroquine                                        | RXNORM            | Extensional | [2.16.840.1.113762.1.4.1032.127](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.127/expansion/20200417) | 12 |

| SARSCoV2 Exposure                                         | ICD10CM, SNOMEDCT | Grouping    | [2.16.840.1.113762.1.4.1032.120](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.120/expansion/20200410) | 2  |
| SARSCoV2 Exposure ICD10CM                                 | ICD10CM           | Extensional | [2.16.840.1.113762.1.4.1032.118](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.118/expansion/20200410) | 1  |
| SARSCoV2 Exposure SNOMEDCT                                | SNOMEDCT          | Extensional | [2.16.840.1.113762.1.4.1032.119](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.119/expansion/20200410) | 1  |
| Suspected COVID19 Infection                               | ICD10CM, SNOMEDCT | Grouping    | [2.16.840.1.113762.1.4.1032.116](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.116/expansion/20200410) | 14 |
| Suspected COVID19 Infection ICD10CM                       | ICD10CM           | Extensional | [2.16.840.1.113762.1.4.1032.106](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.106/expansion/20200410) | 13 |
| Suspected COVID19 Infection SNOMEDCT                      | SNOMEDCT          | Extensional | [2.16.840.1.113762.1.4.1032.115](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.115/expansion/20200410) | 1  |

Coming Soon:


[TOP](#top)

* [Confirmed COVID-19 Infection](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/20200410) (SNOMED CT, ICD-10-CM)
* [SARS-CoV-2 Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/20200417v) (LOINC)
* [SARS-related Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.113/expansion/20200410) (LOINC)


Value sets used here:

* [Confirmed COVID-19 Infection](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/Latest) (SNOMED CT, ICD-10-CM)
* [SARS-CoV-2 Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/Latest) (LOINC)
* [SARS-related Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.113/expansion/Latest) (LOINC)
* Respiratory Condition (ICD-10-CM J00-J99)
* [Hydroxychloroquine](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1564.2220/expansion/Latest) (RxNorm)




* [Confirmed COVID-19 Infection](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.117/expansion/20200410)  (SNOMED CT, ICD-10-CM)
* [SARS-CoV-2 Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.109/expansion/20200417) (LOINC)
* [SARS-related Qualitative Laboratory Test](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.113/expansion/20200410) (LOINC)
* Respiratory Condition (ICD-10-CM J00-J99)
* [Hydroxychloroquine](https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.127/expansion/20200417) (RxNorm)

[TOP](#top)